BIO-key International, Inc. Common Stock (BKYI) Financials
Key financial figures for BIO-key International, Inc. Common Stock (Q2 2026).
BIO-key International, Inc. reported revenue of $1.9 million for Q2 FY2026, up 13.1% from the same period a year earlier. The company posted a net loss of $576.9 thousand, or -$0.56 per share. Operating margin came to -27.57%, against -63.87% a year earlier. Free cash flow for the period was -$845.7 thousand. Across the last 5 reported quarters, quarterly revenue has risen from $1.7 million in Q2 FY2025 to $1.9 million in Q2 FY2026. The figures above are as filed, and the full income statement, balance sheet and cash flow history for BIO-key International, Inc. are on the SentiSense financials page.
- Revenue
- $2M
- Net Income
- -$577K
- EPS
- $-0.56
- Total Assets
- $7M
- Operating Cash Flow
- -$846K
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $2M | -$577K | -$0.56 | -27.57% | -$846K |
| Q1 FY2026 | $2M | -$165K | -$0.20 | -5.49% | -$358K |
| Q4 FY2025 | $1M | -$2M | -$1.85 | -132.38% | -$2M |
| Q3 FY2025 | $2M | -$965K | -$1.46 | -57.57% | -$1M |
| Q2 FY2025 | $2M | -$1M | -$2.01 | -63.87% | -$881K |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $6M | -$5M | -$10.77 | -69.89% | -$5M |
| FY2024 | $7M | -$4M | -$20.88 | -57.88% | -$3M |
| FY2023 | $8M | -$9M | -$152.10 | -113.82% | -$4M |
Frequently asked questions
What was BIO-key International, Inc.'s revenue last quarter?
BIO-key International, Inc. reported revenue of $1.9 million for Q2 FY2026, up 13.1% from the same period a year earlier.
Is BIO-key International, Inc. profitable?
Not in its most recent reported period. BIO-key International, Inc. reported a net loss of $576.9 thousand for Q2 FY2026, a net margin of -30.04% on revenue.
How has BIO-key International, Inc.'s margin trended?
Operating margin was -27.57% in Q2 FY2026, compared with -63.87% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
When does BIO-key International, Inc. report next?
BIO-key International, Inc. is scheduled to report Q3 2026 results on 2026-11-13. That date is an estimate and has not been confirmed by the company.
Full income statement, balance sheet and cash flow for BIO-key International, Inc. Common Stock on SentiSense, with up to forty quarters and twenty fiscal years of history.